Pediatric Perfusion Market Will Grow Rapidly In Coming Years

Pediatric Perfusion Market Summary

The global pediatric perfusion market size was estimated at USD 548.3 million in 2022 and is projected to reach USD 829.1 million by 2030, expanding at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. This market growth is primarily driven by the introduction of technologically advanced pediatric perfusion products, supportive government initiatives, favorable reimbursement policies, the increasing establishment of pediatric cardiac surgery centers, and the rising incidence of congenital heart disease (CHD) and other birth defects among children. These factors collectively create a strong demand for specialized pediatric care and advanced perfusion solutions.

According to the Centers for Disease Control and Prevention (CDC), approximately 16,800 infants are born each year in the United States with a ventricular septal defect, which is a type of congenital heart anomaly. Additionally, nearly 1 million children in the U.S. are currently living with some form of CHD. This high prevalence has significantly increased the demand for effective, safe, and targeted treatment solutions to manage and correct such heart defects. The continued growth of the pediatric perfusion market is also driven by the increasing incidence of both cardiovascular and respiratory disorders in children and the proactive steps taken by public and private sectors to enhance organ donation and transplantation programs.

Key Market Trends & Insights

• In terms of product segmentation, the pediatric perfusion market includes pediatric oxygenators, pediatric cannulae, pediatric blood pumps, pediatric arterial filters, monitoring systems, and other related devices. Among these, pediatric oxygenators emerged as the leading product category in 2022, accounting for the largest market share of 25.8%. This dominance can be attributed to the widespread use of oxygenators during cardiac surgeries in pediatric patients. These devices play a critical role in facilitating effective oxygenation and carbon dioxide removal, ensuring safe and stable cardiopulmonary function during surgical interventions.
• By end-use, the market is segmented into hospitals, cardiac centers, and other healthcare facilities. In 2022, hospitals held the dominant revenue share, accounting for 80.9% of the market. This is largely due to the growing number of children being admitted with cardiac and respiratory complications and the increasing volume of pediatric organ transplant procedures performed in hospital settings. Hospitals typically offer more comprehensive care facilities, multidisciplinary expertise, and access to cutting-edge perfusion technologies, making them the preferred choice for both patients and healthcare providers in managing complex pediatric cases.
• Regionally, North America led the global pediatric perfusion market with a substantial share of 41.6% in 2022. Several key factors contributed to this regional dominance, including the strong presence of established market players, high awareness levels among healthcare professionals and the general population regarding available treatment technologies, a significant number of pediatric CHD cases, and a robust and well-funded healthcare infrastructure. The combination of these factors has ensured consistent demand for advanced perfusion solutions in the region, further supported by ongoing investments in pediatric healthcare services.
• The Asia Pacific region is projected to witness considerable growth in the pediatric perfusion market throughout the forecast period. This anticipated expansion is largely fueled by continuous improvements in healthcare infrastructure, particularly in emerging economies, and a high burden of cardiovascular diseases (CVDs) affecting children. Additionally, various government-led health initiatives aimed at increasing access to pediatric healthcare and promoting early diagnosis and treatment of congenital conditions are expected to play a key role in supporting market growth across countries in this region.

Order a free sample PDF of the Pediatric Perfusion Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2022 Market Size: USD 548.3 million
• 2030 Projected Market Size: USD 829.1 million
• CAGR (2023-2030): 5.4%
• North America: Largest market in 2022

Key Companies & Market Share Insights

Key players in the market focus on various strategic initiatives such as acquisitions, mergers, product approval, and collaborations to boost their market presence and overall position in the market. For instance,in September 2022, LivaNova received FDA ‘510(k) clearance’ for its Essenz heart-lung machine (HLM), allowing the company to launch it commercially in the U.S. Essenz HLM has also been approved by Health Canada and the Japanese PMDA.

Key Players

• Medtronic
• LivaNova PLC
• Terumo Cardiovascular Systems Corporation
• BL Lifesciences
• Cardinal Health
• EUROSETS
• Getinge AB

Browse Horizon Databook on Pediatric Perfusion Market – Global Pediatric Perfusion Size & Outlook

Conclusion

The pediatric perfusion market is poised for stable growth, driven by rising CHD prevalence, technological advancements, and supportive healthcare policies. With North America maintaining dominance due to robust infrastructure and early adoption of innovative technologies, Asia Pacific is rapidly emerging due to healthcare modernization and increasing disease burden. Hospitals continue to lead as the primary end-use segment, while oxygenators dominate product demand. Public awareness, enhanced reimbursement frameworks, and strategic government initiatives will further accelerate market expansion. As surgical techniques and perfusion technologies evolve, the global market will witness increasing investments aimed at improving outcomes for pediatric cardiac and respiratory patients.